3.1400
-0.1400
(-4.27%)
At close: 4:25:43 PM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-40,286.4880
-40,286.4880
-25,395.3210
-39,492.9500
-21,889.3100
Investing Cash Flow
-43,103.9920
-43,103.9920
-58,565.4560
-36,503.5150
-13,432.2900
Financing Cash Flow
18,840.9760
18,840.9760
749.9920
290,758.7150
23,929.1440
End Cash Position
79,602.0690
79,602.0690
144,151.5730
227,362.3580
12,600.1080
Capital Expenditure
-45,334.0880
-45,334.0880
-58,565.4560
-36,503.5150
-13,432.2900
Issuance of Capital Stock
16,792.2460
16,792.2460
749.9920
299,209.9770
22,632.2140
Repayment of Debt
--
--
--
-6,575.5840
-582.9330
Free Cash Flow
-85,620.5760
-85,620.5760
-83,960.7770
-75,996.4650
-35,321.6000
12/31/2020 - 2/24/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ELIC.ST Elicera Therapeutics AB (publ)
3.3600
+1.20%
NXTCL.ST NextCell Pharma AB
2.9200
+1.39%
ACE.ST Ascelia Pharma AB (publ)
2.9150
+1.92%
GANX Gain Therapeutics, Inc.
2.2400
+1.83%
ALZN Alzamend Neuro, Inc.
1.1100
-3.48%
APRE Aprea Therapeutics, Inc.
3.8600
-0.77%
ADPT Adaptive Biotechnologies Corporation
8.00
+1.78%
MIST Milestone Pharmaceuticals Inc.
1.9687
-2.54%
UBX Unity Biotechnology, Inc.
2.2400
+4.71%
ELEV Elevation Oncology, Inc.
0.6845
+2.69%